Beta Bionics, Inc. (BBNX) · Insider trading
What Beta Bionics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$4.55M
8 insiders, 67% under a plan
Net, 12 months
−$4.55M
bought less sold
Latest filing
2026-10-16
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Wellington Hadley Harbor Aggregator IV, L.P.10% owner | $17.00M | – | 1 | 2025-01-31 | 3,901,599 |
| Hopman MarkChief Commercial Officer | – | $2.28M | 20 | 2026-10-14 | 55,334 |
| Feider StephenChief Financial Officer | – | $1.89M | 19 | 2026-09-02 | 159,378 |
| Mensinger MikeChief Product Officer | $566,950 | $579,333 | 14 | 2026-09-16 | 177,390 |
| Saint SeanDirector, President & CEO | – | $911,239 | 9 | 2026-09-03 | 398,429 |
| Jones ChristyDirector | – | $228,214 | 4 | 2026-09-22 | 19,564 |
| Russell Steven JonChief Medical Officer | – | $214,390 | 8 | 2026-09-02 | 169,628 |
| Lezack AdamDirector | – | $100,467 | 6 | 2026-05-22 | 27,399 |
| Palasis MariaDirector | – | $79,388 | 4 | 2025-12-01 | 8,935 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Hopman MarkChief Commercial Officer | Sale | 775 | 17.35 | $13,446 | 55,334 | Form 4 |
| 2026-10-01 | Hopman MarkChief Commercial Officer | Sale | 370 | 18.96 | $7,015 | 56,109 | Form 4 |
| 2026-09-22 | Jones ChristyDirector | Saleplan | 6,430 | 23.00 | $147,890 | 19,564 | Form 4 |
| 2026-09-16 | Hopman MarkChief Commercial Officer | Saleplan | 30,779 | 20.13 | $619,581 | 56,479 | Form 4 |
| 2026-09-16 | Mensinger MikeChief Product Officer | Saleplan | 2,650 | 22.00 | $58,300 | 177,390 | Form 4 |
| 2026-09-14 | Hopman MarkChief Commercial Officer | Saleplan | 775 | 15.52 | $12,028 | 86,382 | Form 4 |
| 2026-09-09 | Hopman MarkChief Commercial Officer | Saleplan | 35,994 | 18.46 | $664,449 | 88,033 | Form 4/A |
| 2026-09-03 | Saint SeanDirector, President & CEO | Saleplan | 5,641 | 20.08 | $113,271 | 398,429 | Form 4 |
| 2026-09-02 | Hopman MarkChief Commercial Officer | Sale | 5,327 | 19.11 | $101,799 | 124,027 | Form 4 |
| 2026-09-02 | Mensinger MikeChief Product Officer | Sale | 4,375 | 19.11 | $83,606 | 180,040 | Form 4 |
| 2026-09-02 | Feider StephenChief Financial Officer | Sale | 6,675 | 19.11 | $127,559 | 159,378 | Form 4 |
| 2026-09-02 | Saint SeanDirector, President & CEO | Sale | 16,867 | 19.11 | $322,328 | 404,070 | Form 4 |
| 2026-09-02 | Russell Steven JonChief Medical Officer | Sale | 4,221 | 19.11 | $80,663 | 169,628 | Form 4 |
| 2026-06-29 | Feider StephenChief Financial Officer | Saleplan | 4,896 | 17.03 | $83,379 | 166,053 | Form 4/A |
| 2026-06-26 | Feider StephenChief Financial Officer | Saleplan | 5,104 | 17.05 | $87,023 | 166,053 | Form 4/A |
| 2026-06-24 | Jones ChristyDirector | Saleplan | 1,406 | 15.00 | $21,090 | 25,994 | Form 4 |
| 2026-06-24 | Hopman MarkChief Commercial Officer | Saleplan | 1,258 | 15.01 | $18,883 | 129,354 | Form 4 |
| 2026-06-04 | Jones ChristyDirector | Saleplan | 2,811 | 14.00 | $39,354 | 27,400 | Form 4 |
| 2026-06-04 | Hopman MarkChief Commercial Officer | Saleplan | 275 | 12.31 | $3,385 | 130,612 | Form 4 |
| 2026-06-02 | Hopman MarkChief Commercial Officer | Sale | 5,329 | 12.61 | $67,199 | 130,887 | Form 4 |
| 2026-06-02 | Mensinger MikeChief Product Officer | Sale | 4,378 | 12.61 | $55,207 | 184,415 | Form 4 |
| 2026-06-02 | Feider StephenChief Financial Officer | Sale | 6,676 | 12.61 | $84,184 | 166,053 | Form 4 |
| 2026-06-02 | Saint SeanDirector, President & CEO | Sale | 16,872 | 12.61 | $212,756 | 420,937 | Form 4 |
| 2026-06-02 | Russell Steven JonChief Medical Officer | Sale | 4,222 | 12.61 | $53,239 | 173,849 | Form 4 |
| 2026-05-22 | Lezack AdamDirector | Saleplan | 998 | 11.21 | $11,188 | 27,399 | Form 4 |
| 2026-05-21 | Lezack AdamDirector | Saleplan | 1,000 | 9.95 | $9,950 | 11,432 | Form 4 |
| 2026-05-21 | Jones ChristyDirector | Saleplan | 1,998 | 9.95 | $19,880 | 13,246 | Form 4 |
| 2026-03-04 | Hopman MarkChief Commercial Officer | Saleplan | 353 | 11.57 | $4,084 | 139,133 | Form 4 |
| 2026-03-02 | Hopman MarkChief Commercial Officer | Sale | 834 | 12.36 | $10,308 | 139,486 | Form 4 |
| 2026-03-02 | Mensinger MikeChief Product Officer | Sale | 1,064 | 12.36 | $13,151 | 188,793 | Form 4 |
| 2026-03-02 | Feider StephenChief Financial Officer | Sale | 1,428 | 12.36 | $17,650 | 172,729 | Form 4 |
| 2026-03-02 | Saint SeanDirector, President & CEO | Sale | 3,384 | 12.36 | $41,826 | 437,809 | Form 4 |
| 2026-03-02 | Russell Steven JonChief Medical Officer | Sale | 1,026 | 12.36 | $12,681 | 179,096 | Form 4 |
| 2026-01-06 | Mensinger MikeChief Product Officer | Saleplan | 2,200 | 30.10 | $66,220 | 80,752 | Form 4 |
| 2026-01-02 | Mensinger MikeChief Product Officer | Saleplan | 7,200 | 29.56 | $212,832 | 83,552 | Form 4 |
| 2026-01-02 | Mensinger MikeChief Product Officer | Saleplan | 600 | 30.20 | $18,120 | 82,952 | Form 4 |
| 2026-01-02 | Feider StephenChief Financial Officer | Saleplan | 20,000 | 29.53 | $590,600 | 42,614 | Form 4 |
| 2025-12-04 | Hopman MarkChief Commercial Officer | Saleplan | 2,061 | 30.66 | $63,190 | 136,216 | Form 4 |
| 2025-12-02 | Hopman MarkChief Commercial Officer | Saleplan | 856 | 29.34 | $25,115 | 138,277 | Form 4 |
| 2025-12-02 | Russell Steven JonChief Medical Officer | Sale | 1,025 | 29.34 | $30,074 | 178,071 | Form 4 |
45 more
| 2025-12-02 | Mensinger MikeChief Product Officer | Sale | 1,063 | 29.34 | $31,188 | 90,752 | Form 4 |
| 2025-12-02 | Feider StephenChief Financial Officer | Sale | 1,427 | 29.34 | $41,868 | 42,614 | Form 4 |
| 2025-12-02 | Saint SeanDirector, President & CEO | Sale | 3,278 | 29.34 | $96,177 | 97,924 | Form 4 |
| 2025-12-01 | Palasis MariaDirector | Saleplan | 906 | 29.33 | $26,573 | 8,935 | Form 4 |
| 2025-12-01 | Palasis MariaDirector | Saleplan | 500 | 29.96 | $14,980 | 8,435 | Form 4 |
| 2025-12-01 | Lezack AdamDirector | Saleplan | 906 | 29.35 | $26,591 | 8,935 | Form 4 |
| 2025-12-01 | Lezack AdamDirector | Saleplan | 500 | 29.91 | $14,955 | 8,435 | Form 4 |
| 2025-10-31 | Palasis MariaDirector | Saleplan | 1,287 | 26.86 | $34,569 | 9,960 | Form 4 |
| 2025-10-31 | Palasis MariaDirector | Saleplan | 119 | 27.45 | $3,267 | 9,841 | Form 4 |
| 2025-10-31 | Lezack AdamDirector | Saleplan | 1,368 | 26.85 | $36,731 | 9,879 | Form 4 |
| 2025-10-31 | Lezack AdamDirector | Saleplan | 38 | 27.70 | $1,053 | 9,841 | Form 4 |
| 2025-10-03 | Feider StephenChief Financial Officer | Saleplan | 3,828 | 21.52 | $82,379 | 45,195 | Form 4 |
| 2025-10-03 | Feider StephenChief Financial Officer | Saleplan | 1,154 | 22.28 | $25,711 | 44,041 | Form 4 |
| 2025-10-01 | Feider StephenChief Financial Officer | Saleplan | 14,918 | 20.76 | $309,698 | 44,141 | Form 4 |
| 2025-10-01 | Feider StephenChief Financial Officer | Saleplan | 100 | 21.08 | $2,108 | 44,041 | Form 4 |
| 2025-09-08 | Feider StephenChief Financial Officer | Saleplan | 9,900 | 21.13 | $209,187 | 44,041 | Form 4 |
| 2025-09-05 | Feider StephenChief Financial Officer | Saleplan | 100 | 21.00 | $2,100 | 44,041 | Form 4 |
| 2025-09-05 | Hopman MarkChief Commercial Officer | Saleplan | 11,411 | 20.56 | $234,610 | 31,215 | Form 4 |
| 2025-09-04 | Hopman MarkChief Commercial Officer | Saleplan | 6,818 | 19.97 | $136,155 | 31,215 | Form 4 |
| 2025-09-02 | Feider StephenChief Financial Officer | Sale | 1,462 | 18.86 | $27,573 | 44,041 | Form 4 |
| 2025-09-02 | Hopman MarkChief Commercial Officer | Sale | 848 | 18.86 | $15,993 | 33,284 | Form 4 |
| 2025-09-02 | Mensinger MikeChief Product Officer | Sale | 1,089 | 18.86 | $20,539 | 91,815 | Form 4 |
| 2025-09-02 | Russell Steven JonChief Medical Officer | Sale | 1,015 | 18.86 | $19,143 | 71,017 | Form 4 |
| 2025-09-02 | Saint SeanDirector, President & CEO | Sale | 3,359 | 18.86 | $63,351 | 101,202 | Form 4 |
| 2025-08-22 | Feider StephenChief Financial Officer | Saleplan | 4,413 | 17.01 | $75,065 | 45,503 | Form 4 |
| 2025-08-19 | Feider StephenChief Financial Officer | Saleplan | 5,587 | 17.03 | $95,147 | 45,503 | Form 4 |
| 2025-08-19 | Hopman MarkChief Commercial Officer | Saleplan | 16,158 | 16.61 | $268,384 | 34,132 | Form 4 |
| 2025-06-02 | Saint SeanDirector, President & CEO | Sale | 943 | 17.03 | $16,059 | 107,057 | Form 4 |
| 2025-06-02 | Saint SeanDirector, President & CEO | Sale | 2,185 | 18.15 | $39,658 | 104,872 | Form 4 |
| 2025-06-02 | Saint SeanDirector, President & CEO | Sale | 311 | 18.69 | $5,813 | 104,561 | Form 4 |
| 2025-06-02 | Feider StephenChief Financial Officer | Sale | 410 | 17.03 | $6,982 | 46,590 | Form 4 |
| 2025-06-02 | Feider StephenChief Financial Officer | Sale | 951 | 18.15 | $17,261 | 45,639 | Form 4 |
| 2025-06-02 | Feider StephenChief Financial Officer | Sale | 136 | 18.69 | $2,542 | 45,503 | Form 4 |
| 2025-06-02 | Mensinger MikeChief Product Officer | Sale | 306 | 17.03 | $5,211 | 93,713 | Form 4 |
| 2025-06-02 | Mensinger MikeChief Product Officer | Sale | 708 | 18.15 | $12,850 | 93,005 | Form 4 |
| 2025-06-02 | Mensinger MikeChief Product Officer | Sale | 101 | 18.69 | $1,888 | 92,904 | Form 4 |
| 2025-06-02 | Russell Steven JonChief Medical Officer | Sale | 285 | 17.03 | $4,854 | 72,786 | Form 4 |
| 2025-06-02 | Russell Steven JonChief Medical Officer | Sale | 660 | 18.15 | $11,979 | 72,126 | Form 4 |
| 2025-06-02 | Russell Steven JonChief Medical Officer | Sale | 94 | 18.69 | $1,757 | 72,032 | Form 4 |
| 2025-06-02 | Hopman MarkChief Commercial Officer | Sale | 238 | 17.03 | $4,053 | 34,762 | Form 4 |
| 2025-06-02 | Hopman MarkChief Commercial Officer | Sale | 551 | 18.15 | $10,001 | 34,211 | Form 4 |
| 2025-06-02 | Hopman MarkChief Commercial Officer | Sale | 79 | 18.69 | $1,477 | 34,132 | Form 4 |
| 2025-01-31 | Wellington Hadley Harbor Aggregator IV, L.P.10% owner | Buy | 1,000,000 | 17.00 | $17.00M | 3,901,599 | Form 4 |
| 2025-01-31 | Mensinger MikeChief Product Officer | Sale | 13 | 17.00 | $221 | 25,669 | Form 4 |
| 2025-01-31 | Mensinger MikeChief Product Officer | Buy | 33,350 | 17.00 | $566,950 | 59,019 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
28 × grant or award13 × option exercise2 × conversion1 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-29 | Feider StephenChief Financial Officer | Option exercise M | +4,896 | 5.10 | 170,949 | Form 4/A |
| 2026-06-26 | Feider StephenChief Financial Officer | Option exercise M | +5,104 | 5.10 | 171,157 | Form 4/A |
| 2026-05-21 | Michel Gerard JDirector | Grant or award A | +16,965 | – | 33,509 | Form 4 |
| 2026-05-21 | Carney SeanDirector | Grant or award A | +16,965 | – | 32,209 | Form 4 |
| 2026-05-21 | Dearen Danny L.Director | Grant or award A | +16,965 | – | 32,209 | Form 4 |
| 2026-05-21 | Palasis MariaDirector | Grant or award A | +16,965 | – | 29,397 | Form 4 |
| 2026-05-21 | Lezack AdamDirector | Grant or award A | +16,965 | – | 28,397 | Form 4 |
| 2026-05-21 | Jones ChristyDirector | Grant or award A | +16,965 | – | 30,211 | Form 4 |
| 2026-02-27 | Hopman MarkChief Commercial Officer | Grant or award A | +109,105 | – | 140,320 | Form 4 |
| 2026-02-27 | Mensinger MikeChief Product Officer | Grant or award A | +109,105 | – | 189,857 | Form 4 |
| 2026-02-27 | Feider StephenChief Financial Officer | Grant or award A | +131,543 | – | 174,157 | Form 4 |
| 2026-02-27 | Saint SeanDirector, President & CEO | Grant or award A | +343,269 | – | 441,193 | Form 4 |
| 2026-02-27 | Russell Steven JonChief Medical Officer | Grant or award A | +109,105 | – | 180,122 | Form 4 |
| 2026-01-13 | Michel Gerard JDirector | Grant or award A | +3,997 | – | 16,544 | Form 4 |
| 2026-01-13 | Carney SeanDirector | Grant or award A | +3,997 | – | 15,244 | Form 4 |
| 2026-01-13 | Dearen Danny L.Director | Grant or award A | +3,997 | – | 15,244 | Form 4 |
| 2026-01-13 | Palasis MariaDirector | Grant or award A | +3,997 | – | 12,432 | Form 4 |
| 2026-01-13 | Lezack AdamDirector | Grant or award A | +3,997 | – | 12,432 | Form 4 |
| 2026-01-13 | Jones ChristyDirector | Grant or award A | +3,997 | – | 15,244 | Form 4 |
| 2026-01-02 | Feider StephenChief Financial Officer | Option exercise M | +20,000 | 5.10 | 62,614 | Form 4 |
| 2025-10-03 | Feider StephenChief Financial Officer | Option exercise M | +4,982 | 5.10 | 49,023 | Form 4 |
| 2025-10-01 | Feider StephenChief Financial Officer | Option exercise M | +15,018 | 5.10 | 59,059 | Form 4 |
| 2025-09-08 | Feider StephenChief Financial Officer | Option exercise M | +9,900 | 5.10 | 53,941 | Form 4 |
| 2025-09-05 | Feider StephenChief Financial Officer | Option exercise M | +100 | 5.10 | 44,141 | Form 4 |
| 2025-09-05 | Hopman MarkChief Commercial Officer | Option exercise M | +11,411 | 5.10 | 42,626 | Form 4 |
| 2025-09-04 | Hopman MarkChief Commercial Officer | Option exercise M | +656 | 5.10 | 33,940 | Form 4 |
| 2025-09-04 | Hopman MarkChief Commercial Officer | Option exercise M | +4,093 | 5.10 | 38,033 | Form 4 |
| 2025-08-22 | Feider StephenChief Financial Officer | Option exercise M | +4,413 | 5.10 | 49,916 | Form 4 |
| 2025-08-19 | Feider StephenChief Financial Officer | Option exercise M | +5,587 | 5.10 | 51,090 | Form 4 |
| 2025-08-19 | Hopman MarkChief Commercial Officer | Option exercise M | +16,158 | 5.10 | 50,290 | Form 4 |
| 2025-03-26 | Michel Gerard JDirector | Grant or award A | +12,547 | – | 12,547 | Form 4 |
| 2025-03-15 | Carney SeanDirector | Grant or award A | +11,247 | – | 11,247 | Form 4 |
| 2025-03-15 | Lezack AdamDirector | Grant or award A | +11,247 | – | 11,247 | Form 4 |
| 2025-03-15 | Dearen Danny L.Director | Grant or award A | +11,247 | – | 11,247 | Form 4 |
| 2025-03-15 | Palasis MariaDirector | Grant or award A | +11,247 | – | 11,247 | Form 4 |
| 2025-03-15 | Jones ChristyDirector | Grant or award A | +11,247 | – | 11,247 | Form 4 |
| 2025-02-27 | Saint SeanDirector, President & CEO | Grant or award A | +108,000 | – | 108,000 | Form 4 |
| 2025-02-27 | Feider StephenChief Financial Officer | Grant or award A | +47,000 | – | 47,000 | Form 4 |
| 2025-02-27 | Mensinger MikeChief Product Officer | Grant or award A | +35,000 | – | 94,019 | Form 4 |
| 2025-02-27 | Russell Steven JonChief Medical Officer | Grant or award A | +35,000 | – | 73,071 | Form 4 |
| 2025-02-27 | Hopman MarkChief Commercial Officer | Grant or award A | +35,000 | – | 35,000 | Form 4 |
| 2025-01-31 | Wellington Hadley Harbor Aggregator IV, L.P.10% owner | Conversion C | +2,901,599 | – | 2,901,599 | Form 4 |
| 2025-01-31 | Mensinger MikeChief Product Officer | Conversion C | +15,107 | – | 15,107 | Form 4 |
| 2025-01-31 | Mensinger MikeChief Product Officer | Option exercise X | +10,575 | 0.02 | 25,682 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.